In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

&nbsp;In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.&nbsp;

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Tune in to the Bell Direct 'Between the Bells' podcast, where we'll cover the latest economic news and updates, market movements and analysis. With daily updates, you can get the information you need to find your investing edge. Find Bell Direct here: Website: https://www.belldirect.com.au/smarter/ Twitter: https://twitter.com/belldirect Facebook: https://www.facebook.com/BellDirectAustralia LinkedIn: https://www.linkedin.com/company/bell-direct/ Instagram: https://www.instagram.com/bell.direct/

Business

Investing

Tune in to the Bell Direct 'Between the Bells' podcast, where we'll cover the latest economic news and updates, market movements and analysis. With daily updates, you can get the information you need to find your investing edge. Find Bell Direct here: Website: https://www.belldirect.com.au/smarter/ Twitter: https://twitter.com/belldirect Facebook: https://www.facebook.com/BellDirectAustralia LinkedIn: https://www.linkedin.com/company/bell-direct/ Instagram: https://www.instagram.com/bell.direct/

Share From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Sign up to save your podcasts

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

More shows like Between the Bells

CommSec Market Update

Motley Fool Money

NAB Morning Call

Your Wealth

The Rules of Investing

Equity Mates Investing Podcast

Australian Investors Podcast

Buy Hold Sell, by Livewire Markets

The Call from ausbiz

The COB from ausbiz

Stock Take

SBS On the Money

On the Couch

Market Updates

the daily moo